TAG and COVID-19 Prevention Network Fall 2020 Webinars
TAG is hosting a series of webinars on COVID-19 biomedical prevention research in collaboration with the CoVPN. Information and videos from the first two events may be found on this page.
TAG is hosting a series of webinars on COVID-19 biomedical prevention research in collaboration with the CoVPN. Information and videos from the first two events may be found on this page.
In these two webinars, Treatment Action Group (TAG) launched the two latest additions to our series of materials designed for community leaders, An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis and An Activist’s Guide to Tuberculosis Diagnostic Tools.
On May 15, TAG Executive Director Mark Harrington presented this testimony to the New York City Council Committee on and Health and the New York Council Committee on Hospitals on Oversight: NYC's Plan for COVID-19 Testing and Contact Tracing.
On Friday April 24th, 2020 ANEA hosted a virtual gathering for HIV/AIDS community organizations and leaders involved in "Ending the Epidemic" state, local, or community initiatives that are experiencing disruptions from the COVID-19 pandemic.
On Friday, April 3, Treatment Action Group (TAG) and Médecins Sans Frontières (MSF), and the Global Coalition of TB Activists (GCTA) held a webinar on the price of Xpert tests for COVID-19, TB, HIV, HCV and other diseases.
Due to the late cancellation of the in-person Conference on Retroviruses and Opportunistic Infections (CROI), the 2020 Pre-CROI Community HIV Cure Research Workshop took place via Zoom conference on Saturday, March 7th. We thank all presenters, panelists and participants -…
On January 22, 2020, Treatment Action Group (TAG), Médecins Sans Frontières (MSF) Access Campaign, Health GAP, IMPAACT4TB, and AVAC presented this webinar on how to engage in PEPFAR COPs advocacy. Materials are online now.
TAG presented an analysis at the 50th Union World Conference on Lung Health, which found that that total public expenditures on the development of bedaquiline, an important medicine for drug-resistant tuberculosis, far exceed those of Johnson & Johnson, the originator company.
TAG, AVAC, The Well Project and the Women’s Research Initiative (WRI) co-convened this webinar on Monday, October 7. It was the first in a two-part series, responding to advocates’ desire to better understand the research to date on F/TAF as…
This webinar took place on June 5 and gave an overview of the recent PrEP pricing advocacy that has taken place, and provided information on how webinar attendees can get more involved in ongoing community efforts to make PrEP affordable…